[Chemoradiotherapy with S-1 for Recurrence Cases of Colorectal Cancer]

Gan To Kagaku Ryoho. 2018 Jan;45(1):136-138.
[Article in Japanese]

Abstract

Introduction: Although chemotherapy is the main treatment for recurrent colorectal cancer, the utility of radiotherapy as a local treatment has been widely reported. We performed chemoradiotherapy with S-1 for cases with recurrence after surgery, and the outcomes are reported herein.

Materials and methods: Chemoradiotherapy with S-1 was performed in 4 cases. S-1 was administered for 2 weeks during the irradiation period, and the off period provided was 1 week.

Results: X-ray irradiation was performed in 2 cases and proton beam irradiation in the other 2. The progression free periods of the 2 cases receiving proton beam irradiation were 31 months and 36 months. In contrast, the progression free periods of the 2 cases given X-ray irradiation were 24 months and 21 months.

Discussion: It is known that S-1 not only achieves a high anticancer effect via dihydropyrimidine dehydrogenase(DPD)inhibition, which is a major metabolic pathway of 5-FU, but also increases the radiation susceptibility of malignancies. S-1 is regarded as an ideal anticancer agent when used in combination with radiation therapy. Since the local control achieved in our 4 cases was good, chemoradiotherapy with S-1 was considered to be a useful treatment.

Publication types

  • Case Reports

MeSH terms

  • Antimetabolites, Antineoplastic / therapeutic use*
  • Chemoradiotherapy*
  • Colorectal Neoplasms / diagnosis
  • Colorectal Neoplasms / therapy*
  • Disease Progression
  • Drug Combinations
  • Female
  • Humans
  • Male
  • Middle Aged
  • Oxonic Acid / therapeutic use*
  • Recurrence
  • Tegafur / therapeutic use*

Substances

  • Antimetabolites, Antineoplastic
  • Drug Combinations
  • S 1 (combination)
  • Tegafur
  • Oxonic Acid